Vaccination in the immunotherapy of glioblastoma-Reference-Cited by-同舟云学术

Vaccination in the immunotherapy of glioblastoma

Published:2017-12-11 Issue:2 Volume:14 Page:255-268
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kong Ziren¹,Wang Yu¹,Ma Wenbin¹

Affiliation:

1. Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1388481

Reference128 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. CGCG clinical practice guidelines for the management of adult diffuse gliomas

3. Epidemiology of Brain Tumors

4. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer immunotherapy of Wilms tumor: a narrative review;Future Oncology;2024-09-05

2. Immunotherapeutic advances in glioma management: The rise of vaccine‐based approaches;CNS Neuroscience & Therapeutics;2024-08-30

3. Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma;Journal of Nanoparticle Research;2024-08

4. High expression of COPZ2 is associated with poor prognosis and cancer progression in glioma;Frontiers in Molecular Neuroscience;2024-07-31

5. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches;International Journal of Molecular Sciences;2024-05-26